subscribeSubscribe
price-trendAsk Us
The top 10 antibody drug conjugate contenders in 2021

The top 10 antibody drug conjugate contenders in 2021
FIERCEPHARMA
13 Sep 2021
Share Share
Wyeth’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US

Wyeth’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US
FDA
29 Feb 2020
Share Share
Wyeth Pharm’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US

Wyeth Pharm’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US
FDA
12 Apr 2018
Share Share
NICE set to reject Pfizer`s leukaemia drug Besponsa

NICE set to reject Pfizer`s leukaemia drug Besponsa
Gemma Jones PMLIVE
22 Aug 2017
Share Share
Wyeth Pharm’s Inotuzumab Ozogamicin Receives Supplemental Approval In US

Wyeth Pharm’s Inotuzumab Ozogamicin Receives Supplemental Approval In US
FDA
18 Aug 2017
Share Share
Pfizer Announces USFDA Acceptance of Inotuzumab Ozogamicin

Pfizer Announces USFDA Acceptance of Inotuzumab Ozogamicin
PRESS RELEASE
21 Feb 2017
Share Share
FDA accepts Pfizer’s blood cancer candidate for speedy review

FDA accepts Pfizer’s blood cancer candidate for speedy review
Ben Adams FIERCE BIOTECH
21 Feb 2017
Share Share
A New Antibody For Treating Acute Lymphocytic Leukemia?

A New Antibody For Treating Acute Lymphocytic Leukemia?
E Schattner FORBES
06 Dec 2016
Share Share
Pfizer hits up four biotechs in $46m R&D collaboration strategy

Pfizer hits up four biotechs in $46m R&D collaboration strategy
Dan Stanton OUT-SOURCING PHARMA
19 Jan 2016
Share Share
Celator Announces Participation in Cardiff University Clinical Trial in Adults

Celator Announces Participation in Cardiff University Clinical Trial in Adults
PR NEWS WIRE
11 Jan 2016
Share Share